Published briefing
Clover Health gets 5-star CMS rating for PPO plans
Clover Health said CMS gave its PPO Medicare Advantage plans a 5-star rating for 2027, affecting payment year 2028.
PipDig Newsroom ·
Read briefingMarket News
The following Forex news reports are the latest developments of the Forex market. The news reports are updated frequently and include all the events that affect the foreign exchange trading industry.
More briefings
Published briefing
Helium Evolution names Anton du Plessis to board, eyes 2027 drilling
Helium Evolution said Grasslands seismic work is done and drilling could start as early as January 2027, while it added Anton du Plessis to the board.
Read briefing
Published briefing
Bombardier adds Sydney line maintenance station
Bombardier added a new line maintenance station in Sydney on Oct. 8, expanding its APAC support network to 11 stations worldwide.
Read briefing
Published briefing
Gray closes $600 million refinancing package
Gray Media closed a $600 million Term Loan G and trimmed its revolver to $680 million, extending both maturities to July 15, 2030.
Read briefing
Published briefing
Copa Holdings September traffic rises 17.1%
Copa Holdings reported preliminary September 2026 passenger traffic, with RPMs up 17.1% and load factor at 87.9%.
Read briefing
Published briefing
Associated Capital prelim Q3 book value at $45.40 to $45.60
Associated Capital Group said on Oct. 8 it expects third-quarter book value of $45.40 to $45.60 per share, versus $45.41 at June 30.
Read briefing
Published briefing
Alkane reports A$459 million cash, bullion and investments
Alkane Resources reported A$459 million in cash, bullion and listed investments at the September quarter end, and said FY27 guidance remains unchanged.
Read briefing
Published briefing
Bitdeer AI signs 10-year Malaysia data center deal for 67MW campus
Bitdeer AI signed a 10-year data center services agreement for A901, a 67MW AI Cloud campus in Malaysia, with delivery targeted from the first quarter of 2027.
Read briefing
Published briefing
Pharvaris says Lancet study shows rapid relief with deucrictibant
Pharvaris said RAPIDe-3 data published in The Lancet showed deucrictibant IR eased HAE attacks in 1.28 hours and resolved symptoms in 11.95 hours.
Read briefing